Research output per year
Research output per year
- 21 results
Search results
-
2025
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting
Berg, S. A., La Rosa, S., Zhang, T., Pierorazio, P. M., Albiges, L., Beckermann, K. E., Campbell, M. T., Carlo, M. I., Coleman, K., George, D. J., Geynisman, D. M., Johnson, R., Jonasch, E., Maranchie, J. K., McGregor, B. A., Shapiro, D. D., Singer, E. A., Shuch, B. M., Stadler, W. M. & Tannir, N. M. & 4 others, , Mar 2025, In: Urologic Oncology: Seminars and Original Investigations. 43, 3, p. 135-146 12 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
2023
Current Status and Future Direction to Address Disparities in Diversity, Equity, and Inclusion in Prostate Cancer Care
Fu, J., Fu, C., Wang, R. S., Geynisman, D. M., Ghatalia, P., Lynch, S. M., Harrison, S. R., Tagai, E. K. & Ragin, C., Jul 2023, In: Current Oncology Reports. 25, 7, p. 699-708 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations -
Role of perioperative immunotherapy in localized renal cell carcinoma
Kaur, J., Patil, G., Geynisman, D. M. & Ghatalia, P., Jan 1 2023, In: Therapeutic Advances in Medical Oncology. 15Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
2022
Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell Carcinoma
Zarrabi, K. K., Lanade, O. & Geynisman, D. M., Oct 2022, In: Cancers. 14, 19, 4607.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
The past, present, and future of pT0 in bladder cancer clinical trials
Schober, J. P., Plimack, E., Geynisman, D. & Zibelman, M., Sep 1 2022, In: Current Opinion in Urology. 32, 5, p. 495-499 5 p.Research output: Contribution to journal › Review article › peer-review
4 Scopus citations -
2021
A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer
Geynisman, D. M., Maranchie, J. K., Ball, M. W., Bratslavsky, G. & Singer, E. A., Sep 2021, In: Urologic Oncology: Seminars and Original Investigations. 39, 9, p. 548-560 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access14 Scopus citations -
Role of immunotherapy in localized muscle invasive urothelial cancer
Kaur, J., Choi, W., Geynisman, D. M., Plimack, E. R. & Ghatalia, P., 2021, In: Therapeutic Advances in Medical Oncology. 13, p. 17588359211045858Research output: Contribution to journal › Review article › peer-review
Open Access17 Scopus citations -
2020
Mutations in renal cell carcinoma
D'Avella, C., Abbosh, P., Pal, S. K. & Geynisman, D. M., Oct 2020, In: Urologic Oncology: Seminars and Original Investigations. 38, 10, p. 763-773 11 p.Research output: Contribution to journal › Review article › peer-review
69 Scopus citations -
2019
Economic Burden of Renal Cell Carcinoma—Part I: An Updated Review
Chien, C. R., Geynisman, D. M., Kim, B., Xu, Y. & Shih, Y. C. T., Mar 12 2019, In: PharmacoEconomics. 37, 3, p. 301-331 31 p.Research output: Contribution to journal › Review article › peer-review
Open Access19 Scopus citations -
2018
Approved checkpoint inhibitors in bladder cancer: which drug should be used when?
Ghatalia, P., Zibelman, M., Geynisman, D. M. & Plimack, E., Jan 1 2018, In: Therapeutic Advances in Medical Oncology. 10, p. 1758835918788310Research output: Contribution to journal › Review article › peer-review
Open Access54 Scopus citations -
2017
Biosimilar biologic drugs: a new frontier in medical care
Geynisman, D. M., De Velasco, G., Sewell, K. L. & Jacobs, I., May 19 2017, In: Postgraduate Medicine. 129, 4, p. 460-470 11 p.Research output: Contribution to journal › Review article › peer-review
10 Scopus citations -
Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma
Ghatalia, P., Zibelman, M., Geynisman, D. M. & Plimack, E. R., Jan 1 2017, In: Current Treatment Options in Oncology. 18, 1, p. 7 7.Research output: Contribution to journal › Review article › peer-review
47 Scopus citations -
2016
Bladder Preservation Therapy: A Review of the Literature and Future Directions
Cahn, D. B., Ristau, B. T., Ghiraldi, E. M., Churilla, T. M., Geynisman, D. M., Horwitz, E. M., Uzzo, R. G. & Smaldone, M. C., Oct 1 2016, In: Urology. 96, p. 54-61 8 p.Research output: Contribution to journal › Review article › peer-review
13 Scopus citations -
Checkpoint inhibitors for renal cell carcinoma: Current landscape and future directions
Zibelman, M., Ghatalia, P., Geynisman, D. M. & Plimack, E. R., May 2016, In: Immunotherapy. 8, 7, p. 785-798 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access7 Scopus citations -
Targeted therapy for metastatic urothelial cancer: A work in progress
Plimack, E. R. & Geynisman, D. M., Jun 20 2016, In: Journal of Clinical Oncology. 34, 18, p. 2088-2092 5 p.Research output: Contribution to journal › Review article › peer-review
8 Scopus citations -
2015
Muscle-invasive urothelial bladder cancer: An update on systemic therapy
Knollman, H., Godwin, J. L., Jain, R., Wong, Y. N., Plimack, E. R. & Geynisman, D. M., Dec 2015, In: Therapeutic Advances in Urology. 7, 6, p. 312-330 19 p.Research output: Contribution to journal › Review article › peer-review
Open Access35 Scopus citations -
The hallmarks of cancer: Relevance to the pathogenesis of polycystic kidney disease
Seeger-Nukpezah, T. N., Geynisman, D. M., Nikonova, A. S., Benzing, T. & Golemis, E. A., Sep 25 2015, In: Nature Reviews Nephrology. 11, 9, p. 515-534 20 p.Research output: Contribution to journal › Review article › peer-review
Open Access113 Scopus citations -
2014
A review of economic impact of targeted oral anticancer medications
Shen, C., Chien, C. R., Geynisman, D. M., Smieliauskas, F. & Shih, Y. C. T., Feb 2014, In: Expert Review of Pharmacoeconomics and Outcomes Research. 14, 1, p. 45-69 25 p.Research output: Contribution to journal › Review article › peer-review
17 Scopus citations -
Cost-effectiveness analyses of targeted oral anti-cancer drugs: A systematic review
Smieliauskas, F., Chien, C. R., Shen, C., Geynisman, D. M. & Shih, Y. C. T., Jul 2014, In: PharmacoEconomics. 32, 7, p. 651-680 30 p.Research output: Contribution to journal › Review article › peer-review
24 Scopus citations -
Economic evaluation of therapeutic cancer vaccines and immunotherapy: A systematic review
Geynisman, D. M., Chien, C. R., Smieliauskas, F., Shen, C. & Shih, Y. C. T., Nov 1 2014, In: Human Vaccines and Immunotherapeutics. 10, 11, p. 3415-3424 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access35 Scopus citations -
2012
Toward personalized treatment of advanced biliary tract cancers.
Geynisman, D. M. & Catenacci, D. V. T., Jul 2012, In: Discovery medicine. 14, 74, p. 41-57 17 p.Research output: Contribution to journal › Review article › peer-review
31 Scopus citations